Cargando…

Use of Pulsed Low–Dose Rate Radiotherapy in Refractory Malignancies()()

BACKGROUND: Most tumor cell lines exhibited low-dose hyperradiosensitivity (LDHRS) to radiation doses lower than 0.3 Gy. Pulsed low–dose rate radiotherapy (PLDR) took advantage of LDHRS and maximized the tumor control process. In this study, we retrospectively analyzed patients receiving PLDR for re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Jing, Yang, Ju, Yang, Yang, Ren, Wei, Liu, Juan, Gao, Shanbao, Li, Shuangshuang, Kong, Weiwei, Zhu, Lijing, Yang, Mi, Qian, Xiaoping, Liu, Baorui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2018
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756059/ https://www.ncbi.nlm.nih.gov/pubmed/29306203 http://dx.doi.org/10.1016/j.tranon.2017.12.004

Ejemplares similares

Use of Radiomics Combined With Machine Learning Method in the Recurrence Patterns After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: A Preliminary Study
por: Li, Shuangshuang, et al.
Publicado: (2018)

Malignant triton tumor of the anterior mediastinum: A case report
por: REN, WEI, et al.
Publicado: (2014)

Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results
por: Kutuk, Tugce, et al.
Publicado: (2022)

Low dose irradiation increases adoptive cytotoxic T lymphocyte migration in gastric cancer
por: Du, Juan, et al.
Publicado: (2017)

Pulsed reduced dose-rate radiotherapy for previously irradiated tumors in the brain and spine
por: Prabhu, Arpan V., et al.
Publicado: (2021)

Biomarkers predicting resistance to epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer with wild-type KRAS
por: Liu, Jiang, et al.
Publicado: (2016)

ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel
por: Wang, Lifeng, et al.
Publicado: (2008)

Pathological complete response following neoadjuvant radiotherapy and intraperitoneal perfusion chemotherapy for recurrent colon carcinoma: A case report and literature review
por: BIAN, XINYU, et al.
Publicado: (2016)

Strain elastography imaging for early detection and prediction of tumor response to concurrent chemo-radiotherapy in locally advanced cervical cancer: feasibility study
por: Xu, Yan, et al.
Publicado: (2017)

Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging
por: Zhu, Li, et al.
Publicado: (2016)

Benefits of intraoral stents for sparing normal tissue in radiotherapy of nasopharyngeal carcinoma: a radiobiological model-based quantitative analysis
por: Hou, Zhen, et al.
Publicado: (2021)

Refractory Riedel’s thyroiditis managed with low dose radiotherapy
por: Lawless, Anna, et al.
Publicado: (2022)

Tumor‐penetrating peptide internalizing RGD enhances radiotherapy efficacy through reducing tumor hypoxia
por: Meng, Fanyan, et al.
Publicado: (2022)

Predictive and prognostic value of intravoxel incoherent motion (IVIM) MR imaging in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy
por: Zhu, Li, et al.
Publicado: (2017)

Safety and efficacy of pulsed low-dose rate radiotherapy for local recurrent esophageal squamous cell carcinoma after radiotherapy: Study protocol for a prospective multi-center phase II trial
por: Li, Jie, et al.
Publicado: (2019)

Feasibility of lattice radiotherapy using proton and carbon-ion pencil beam for sinonasal malignancy
por: Yang, Dong, et al.
Publicado: (2022)

Efficacy of low-dose radiotherapy for refractory mycosis fungoides of the face
por: Masters, Adrianna Henson, et al.
Publicado: (2019)

Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer
por: Shi, Zhan, et al.
Publicado: (2022)

The Efficacy and Safety of Hypofractionated Radiation Therapy With Tomotherapy for Advanced or Recurrent Hepatocellular Carcinoma
por: Shen, Jie, et al.
Publicado: (2021)

Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy
por: Meng, Jie, et al.
Publicado: (2016)

Integrative analysis and validation of dysregulated long non‐coding RNAs in colon cancer
por: Zhang, Qun, et al.
Publicado: (2020)

Pulsed dose rate brachytherapy of lip cancer
por: Serkies, Krystyna, et al.
Publicado: (2013)

Pulsed dose rate brachytherapy – is it the right way?
por: Skowronek, Janusz
Publicado: (2010)

Plasma mRNA as liquid biopsy predicts chemo-sensitivity in advanced gastric cancer patients
por: Shen, Jie, et al.
Publicado: (2017)

Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes
por: Bovi, Joseph A., et al.
Publicado: (2020)

Gambogic acid regulates the migration and invasion of colorectal cancer via microRNA-21-mediated activation of phosphatase and tensin homolog
por: Gao, Guangyi, et al.
Publicado: (2018)

Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment
por: Zhang, Zhen, et al.
Publicado: (2017)

Enhancement of Radiation Effects by Ursolic Acid in BGC-823 Human Adenocarcinoma Gastric Cancer Cell Line
por: Yang, Yang, et al.
Publicado: (2015)

Significant benefit of nivolumab combining radiotherapy in metastatic gallbladder cancer patient with strong PD-L1 expression: a case report
por: Kong, Weiwei, et al.
Publicado: (2019)

High-dose-rate and pulsed-dose-rate brachytherapy for oral cavity cancer and oropharynx cancer
por: Polo, Alfredo
Publicado: (2010)

Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag
por: Anwer, Faiz, et al.
Publicado: (2015)

Association of Radiotherapy for Rectal Cancer and Second Gynecological Malignant Neoplasms
por: Guan, Xu, et al.
Publicado: (2021)

FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer: A meta-analysis
por: Chen, Datian, et al.
Publicado: (2018)

Antitumor effect of manumycin on colorectal cancer cells by increasing the reactive oxygen species production and blocking PI3K-AKT pathway
por: Zhang, Jingyu, et al.
Publicado: (2016)

Trends and outcomes of neoadjuvant radiotherapy compared with postoperative radiotherapy for malignant breast cancer
por: Fu, Wenyan, et al.
Publicado: (2018)

Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children
por: You, Sun Young, et al.
Publicado: (2014)

Key changes in the future clinical application of ultra-high dose rate radiotherapy
por: Lin, Binwei, et al.
Publicado: (2023)

Local Tumor Control and Normal Tissue Toxicity of Pulsed Low-Dose Rate Radiotherapy for Recurrent Lung Cancer: An In Vivo Animal Study
por: Zhang, Peng, et al.
Publicado: (2015)

Targeting VEGF/VEGFR to Modulate Antitumor Immunity
por: Yang, Ju, et al.
Publicado: (2018)

Nanoscale optical pulse limiter enabled by refractory metallic quantum wells
por: Qian, Haoliang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v0iabsmvf82st31h8pgi3iu0bu